Immunising against meningococcal serogroup Y using proteins

• 收藏
• 分享

专利权人:

Novartis Vaccines and Diagnostics S.r.l.

发明人:

Pizza, Mariagrazia,Contorni, Mario,Giuliani, Marzia

申请号：

AU2013203816

公开号：

AU2013203816A1

申请日:

2013.04.11

申请国别(地区):

AU

年份:

2013

代理人:

摘要：

#$%^&*AU2013203816A120130502.pdf#####ABSTRACT The established dogma for meningococcus is thus that immunisation against serogroups A, C, W135 and Y shall be based on the four different capsular saccharides, and that immunisation against serogroup B shall not be based on the capsular saccharide. In contrast, the invention uses polypeptide antigens and/or OMVs to immunise against serogroups A, C, W135 and Y (and against serogroup Y in particular). Serogroup B polypeptides can achieve this protection, thus permitting a single polypeptide-based vaccine to be used for protecting against all of serogroups A, B, C, W 135 and Y.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/